Impact of Concomitant Mitral Regurgitation in Moderate Aortic Stenosis: Assessment of Remodeling and Clinical Outcomes [0.03%]
中度主动脉瓣狭窄并发二尖瓣反流的影响：重塑和临床结果的评估
El-Moatasem Gabr,Mianli Xiao,Mujtaba Saeed et al.
El-Moatasem Gabr et al.
Background: Patients with moderate aortic stenosis (AS) and concomitant mitral regurgitation (MR) often present with symptoms despite neither lesion individually reaching intervention thresholds. The clinical impact of th...
Prognostic Value of Tricuspid Regurgitation in Pulmonary Hypertension and Among the Different WHO Groups [0.03%]
三尖瓣反流在肺动脉高压中的预后价值及其在不同WHO功能组中的差异分析
Jwan A Naser,Hossam H Ibrahim,Serena Rahme et al.
Jwan A Naser et al.
Background: Secondary tricuspid regurgitation (STR) is frequently observed in patients with pulmonary hypertension (PH). Whether it independently confers mortality risk beyond the associated right ventricular (RV) dysfunc...
Masses and Malignancy: Toward Integrated Multimodality Cardiac Imaging [0.03%]
心脏多重影像模态的整合与应用：从解剖到机能至分子影像医学论坛报告摘要
Kate Hanneman,Maria Clara Lorca
Kate Hanneman
Impact of Residual Mitral Regurgitation and Gradient After M‑TEER: 1‑Year Outcomes From the CLASP IID Trial [0.03%]
CLASP IID研究中M‑TEER术后残留二尖瓣反流和压差的影响：1年随访结果
Akhil Narang,Jörg Hausleiter,D Scott Lim et al.
Akhil Narang et al.
Background: Reduction of mitral regurgitation (MR) in mitral transcatheter edge-to-edge repair (M-TEER) improves patient outcomes and is balanced against elevated mitral valve gradients (MVGs). ...
Current Status and Future Research Priorities for CMR Cardiomyopathy Assessment: Exciting Times for Protons and Patients [0.03%]
心脏磁共振心肌病评估的现状与未来研究重点：质子和患者的激动人心的时代
Jonathan W Weinsaft,Raymond Y Kwong,Y Chandrashekhar
Jonathan W Weinsaft
REPLY: From Curves to Clinic: Making CTA-Guided Statins Actionable [0.03%]
从曲率到临床：使CTA引导的他汀类药物治疗具有操作性
Bálint Szilveszter,Márton Kolossváry
Bálint Szilveszter
Shanshan Gao,Jingjjing Mu,Yongkai Lu
Shanshan Gao
REPLY: Heterogeneity and Beyond: Unaddressed Pitfalls in the Meta-Analysis of Advanced CTA for MACE Prediction [0.03%]
关于高级CTA预测MACE的Meta分析未解决的问题：超越异质性
Emiliano Bianchini,Faisal Sharif
Emiliano Bianchini
REPLY: Beyond Global Viability: Patient-Specific Identification of Jeopardized Myocardium to Guide Revascularization [0.03%]
回复：超越全球可行性：患者特异性识别受损心肌以指导再血管化
Jacob Abdaem,Dina Labib,James A White et al.
Jacob Abdaem et al.